Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 10/20 | 0.76 |
| ▸ | EGFR | P00533 | 4/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.66 |
| ▸ | MEN1 | O00255 | 4/20 | 0.66 |
| ▸ | MAPT | P10636 | 3/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.59 |
| ▸ | NPC1 | O15118 | 1/20 | 0.59 |
| ▸ | POLB | P06746 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.52 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8647197 | 0.88 | ALDH1A1 (0.64) | DNM1EGFRKMT2AMEN1MAPT | |
| SCHEMBL848237 | 0.86 | DNM1 (1.00) | DNM1EGFRKMT2AMEN1MAPT | |
| SCHEMBL848238 | 0.86 | DNM1 (1.00) | DNM1EGFRKMT2AMEN1MAPT | |
| SCHEMBL847685 | 0.78 | DNM1 (0.78) | DNM1EGFRKMT2AMEN1MAPT | |
| SCHEMBL847684 | 0.78 | DNM1 (0.78) | DNM1EGFRKMT2AMEN1MAPT | |
| SCHEMBL5461358 | 0.77 | DNM1 (0.79) | DNM1EGFRKMT2AMEN1MAPT | |
| SCHEMBL5461355 | 0.77 | DNM1 (0.79) | DNM1EGFRKMT2AMEN1MAPT | |
| SCHEMBL5461360 | 0.77 | DNM1 (0.79) | DNM1EGFRKMT2AMEN1MAPT | |
| SCHEMBL5597169 | 0.74 | DNM1 (0.60) | DNM1EGFRKMT2AMEN1MAPT | |
| SCHEMBL4485755 | 0.74 | DNM1 (0.60) | DNM1EGFRKMT2AMEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6699463-B2 | Photostable cationic organic sunscreen compounds with antioxidant properties and compositions obtained therefrom | EM INDUSTRIES | 2004-03-02 | — | — | US | disclosed |
| US-20030198607-A1 | Photostable cationic organic sunscreen compounds with antioxidant properties and compositions obtained therefrom | EM INDUSTRIES | 2003-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030198607-A1 | Photostable cationic organic sunscreen compounds with antioxidant properties and compositions obtained therefrom | DOHH, CYC1, TYR | DNM1 4774/4885EGFR 804/4885KMT2A 3540/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.